This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Monster Beverage (MNST) Surges on Q1 Earnings & Sales Beat
by Zacks Equity Research
Monster Beverage (MNST) posts top and bottom-line beat in first-quarter 2019, driven by strong sales for the Monster Energy brand energy drinks and the launch of Reign Total Body Fuel.
3 Large-Cap Stocks for Income Investors to Buy Right Now
by Benjamin Rains
We have highlighted three well-known large-cap stocks that present solid dividend yields and earn a Zacks Rank #2 (Buy) or better at the moment.
Molson Coors (TAP) Stock Falls on Q1 Earnings & Sales Miss
by Zacks Equity Research
Molson Coors' (TAP) top and bottom lines miss estimates in first-quarter 2019, driven by soft volume, offset by higher pricing.
FEMSA (FMX) Q1 Earnings Miss Estimates, Sales Improve Y/Y
by Zacks Equity Research
FEMSA (FMX) reports strong top line in first-quarter 2019, backed by strength across all segments.
Zacks.com featured highlights include: PepsiCo, Raymond James, Kansas City Southern, Fortive and Abbott Laboratories
by Zacks Equity Research
Zacks.com featured highlights include: PepsiCo, Raymond James, Kansas City Southern, Fortive and Abbott Laboratories
Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?
by Sweta Killa
Sector ETF report for FSTA
Cadence Design Systems, Red Robin Gourmet Burgers, PepsiCo and Coca-Cola highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Cadence Design Systems, Red Robin Gourmet Burgers, PepsiCo and Coca-Cola highlighted as Zacks Bull and Bear of the Day
Solid Sales Growth Makes These 5 Stocks Worth Buying Now
by Swayta Shah
Sales growth is an early indicator of the company's future earnings performance.
Boston Beer (SAM) Rises on Q1 Earnings Beat, Strong Shipments
by Zacks Equity Research
Boston Beer's (SAM) first-quarter earnings and sales gain from strong shipment volume and depletions growth. The company perks up shipments and depletions view for 2019.
The Cola Wars: Pepsi vs. Coke
by Daniel Laboe
Over the past 5 trading days PepsiCo (PEP) and Coca-Cola (KO) both posted strong Q1 results pushing these stocks higher. The "Cola Wars" between PepsiCo and Coca-Cola have been waging for over a century. Each of them aggressively building their brand at the expense of the other.
Coca-Cola (KO) Stock Rises on Q1 Earnings and Sales Beat
by Zacks Equity Research
Coca-Cola's (KO) first-quarter earnings and sales top estimates, benefiting from organic revenue growth across all segments as well as execution of growth strategies.
Top 5 ROE Stocks to Buy on Better-Than-Expected Q1 Earnings
by Supriyo Bose
ROE helps investors distinguish profit-generating companies from profit burners and is useful in determining the financial health of a company.
Stock Market News For Apr 18, 2019
by Zacks Equity Research
Wall Street closed lower on Wednesday as stiff loses of the healthcare sector negated the positive impact of strong first quarter earnings results.
PepsiCo at All-Time High Post Earnings: Staples ETFs in Focus
by Sanghamitra Saha
PepsiCo shares jump 3.8% in the key trading session after beating on the both lines in Q1 earnings. The results boost these staples ETFs.
Pepsi Outperforms, Can Coke Follow?
by Daniel Laboe
PepsiCo (PEP) stock soared over 3% this morning following a huge earnings beat, hitting an all-time high of $126.85. Earnings came in at $0.97 per share vs. the $0.92 estimate and sales were reported at $12.88 billion vs. the estimated $12.65 billion, both of which illustrated YoY growth. KO is announcing Q1 earnings one week from today on April 24th.
Economic & Earnings Data Deluge
by Zacks Equity Research
Economic & Earnings Data Deluge
Q1 Earnings Beats Ahead of the Bell, Plus Lower Trade Deficit
by Mark Vickery
Morgan Stanley (MS), PepsiCo (PEP) and Kansas City Southern (KSU) are among those companies putting out Q1 earnings results this morning.
PepsiCo (PEP) Q1 Earnings & Sales Beat Estimates, Stock Up
by Zacks Equity Research
PepsiCo's (PEP) first-quarter 2019 results gain from strong operating performance at international divisions, and North America snacks and beverage businesses. The company reiterates view for 2019.
Hormel Foods Refines Portfolio, Completes CytoSport Sale
by Zacks Equity Research
Post the sale of CytoSport, the Evolve and Muscle Milk brands are no longer part of Hormel Foods' (HRL) business.
PepsiCo Closes CytoSport Buyout, Fortifies Nutrition Portfolio
by Zacks Equity Research
PepsiCo (PEP) buys the CytoSport business from Hormel Foods for $465 million. Muscle Milk and Evolve brands are likely to enhance PepsiCo's nutrition portfolio.
Analysts Estimate PepsiCo (PEP) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
PepsiCo (PEP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors Likely to Decide PepsiCo's (PEP) Fate in Q1 Earnings
by Zacks Equity Research
PepsiCo (PEP) displays strength on the back of robust performance at the international and snacking businesses. However, headwinds linked to the CSD category and adverse currency cannot be ignored.
Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?
by Sweta Killa
Sector ETF report for FSTA
3 Reasons to Add Monster Beverage (MNST) to Your Portfolio
by Zacks Equity Research
Monster Beverage (MNST) is well poised for growth, driven by momentum in the energy drinks business and strong international presence.
Here's What You Must Know About Keurig Dr Pepper (KDP) Stock
by Zacks Equity Research
Keurig Dr Pepper's (KDP) growth strategies like acquisitions and partnerships position it for long-term growth. However, softness in the Coffee Systems business remains a hurdle.